15.69%| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 15.69 | 14.56 | -1.71 | 5.61 | NA |
| Classification | 14.05 | 14.78 | -4.10 | 2.15 | -1.14 |
| Index (S&P 500) | 20.90 | 21.30 | -6.10 | 0.30 | -0.70 |
| % Rank in Class (1-best,100=worst) | 40 | 46 | 28 | 14 | NA |
| Investment Objective: | Long/Short Equity |
|---|---|
| Net Assets ($Mil) | 936.00 |
| Inception Date: | 6/30/00 |
| Manager Name, Tenure | Bath/Bingaman/Dillon, 2002 / 2007 / 2000 |
| Expense Ratio: | 1.45% |
|
Sales Charge:
Load Type:
|
Front-End Load 5.00% 0.00% |
| Company Name | Symbol | % Net Assets |
|---|---|---|
| Jpmorgan Us Government Money Market Fund;capital | NA | 8.27 |
| Jpmorgan 100% Us Treas Secs Mny Mkt Fund;capital | NA | 4.95 |
| Apache | APA | 4.31 |
| Occidental Petroleum Corp | OXY | 4.22 |
| Anadarko Petroleum Corp | APC | 3.80 |
| Medtronic Inc | MDT | 3.37 |
| United Technologies Corp | UTX | 3.21 |
| Devon Energy Corp | DVN | 3.12 |
| Procter & Gamble Co | PG | 3.00 |
| Abbott Laboratories | ABT | 2.96 |
| % of Total Holdings | 41.21 | |